Nutri Pharma ASA - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Nutri Pharma ASA. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Nutri Pharma ASA. The Group's principal activity is to develop products that beneficially influence lifestyle related disorders. The lifestyle related diseases are obesity, hyperlipidaemia and type 2 diabetes. The Group develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The soy technology prevents the development of life style related diseases such as obesity, elevated cholesterol levels and type 2 diabetes. The Group operates in two segments: Royalty and Direct Sales. Products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment).

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report